Peeteepoo, my only thought on this is...how do you best determine the optimum phase 2 dose without these markers for each dose?
I guess you could base it on adverse effects only, so go to highest dose that shows no adverse effects. But this doesnt seem optimal.
Surely to give a potential phase 2 the best shot they'll take these samples across all dosing regimes? But possibly they won't publish them to the mushrooms.
Peeteepoo, my only thought on this is...how do you best...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.015(7.69%) |
Mkt cap ! $93.45M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.5¢ | 19.5¢ | $459.0K | 2.222M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 103700 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 127225 | 3 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |